These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7414441)

  • 41. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The erythrocyte phenotype in ABO and Rh blood groups in blood donors and blood recipients in a hospital setting of Cameroon: adapting supply to demand].
    Tagny CT; Fongué VF; Mbanya D
    Rev Med Brux; 2009; 30(3):159-62. PubMed ID: 19642486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [ABO polymorphism in blood donors in Morocco].
    Habti N; Nourichafi N; Benchemsi N
    Transfus Clin Biol; 2004 Apr; 11(2):95-7. PubMed ID: 15120106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A1 and A2 Sub-Types of Blood Group 'A': A Reflection of their Prevalence in North Karnataka Region.
    Giriyan SS; Agrawal A; Bajpai R; Nirala NK
    J Clin Diagn Res; 2017 May; 11(5):EC40-EC42. PubMed ID: 28658771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
    Arslan O
    Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Problems in blood transfusion (author's transl)].
    Tokunaga A
    Masui; 1982 Mar; 31(3):198-202. PubMed ID: 7109215
    [No Abstract]   [Full Text] [Related]  

  • 48. [Molecular biology and serology in the ABO system].
    Sonneborn HH
    Beitr Infusionsther Transfusionsmed; 1994; 32():142-5. PubMed ID: 9480071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of HIV-1 infection in dried blood spots from a 12-year-old ABO bedside test card.
    Strobel E; Emminger C; Mayer G; Eberle J; Gürtler L
    Vox Sang; 1998; 75(4):303-5. PubMed ID: 9873266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants.
    Damodar S; George B; Mammen J; Mathews V; Srivastava A; Chandy M
    Bone Marrow Transplant; 2005 Aug; 36(3):233-5. PubMed ID: 15908965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Frequency of subgroups of the antigen “a” among volunteer donors].
    Parra-Jaramillo K; Chiriboga-Ponce RF
    Gac Med Mex; 2018; 154(1):22-25. PubMed ID: 29420517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of angio-immunoblastic lymphadenopathy with dysproteinemia--with special reference to immunological approach on DNA antibody, toxoplasma antibody and cold hemagglutinin (author's transl)].
    Tsutsui M; Takenaka T; Miyamoto K; Maeda J; Tsuda T; Shimizu E; Yamamoto H
    Rinsho Ketsueki; 1980 Jul; 21(7):999-1006. PubMed ID: 7420747
    [No Abstract]   [Full Text] [Related]  

  • 53. [Blastic transformation of lymphocytes and use in clinical practice (author's transl)].
    Haskovcová H; Pössnerová V; Strejcek J
    Cas Lek Cesk; 1974; 113(12):355-7. PubMed ID: 4824566
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinically significant autoantibodies--a case report.
    Sulochana PV; Sathyabhama S; Mathai J; Devi KS
    Indian J Pathol Microbiol; 2003 Apr; 46(2):246-7. PubMed ID: 15022929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The frequency of ABO blood groups and the expression of group antigens and isohemagglutinins in Syrian Arabs].
    Sakharov RS; Nofal' KhK
    Sud Med Ekspert; 1996; 39(2):34-6. PubMed ID: 8754514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Screening of allo-antibodies of blood groups in blood donors (author's transl)].
    Kout M; Kubícková Z
    Cas Lek Cesk; 1980 Oct; 119(40-41):1085-7. PubMed ID: 7285065
    [No Abstract]   [Full Text] [Related]  

  • 57. The prevalence of ABO blood group antigens and antibodies in Lagos State, Nigeria.
    Ahmed OA; Agomo PU; Olukoya DK; Esan GJ
    Afr J Med Med Sci; 1993 Sep; 22(3):49-53. PubMed ID: 7839912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Transfusion security "immunologic security"].
    Gargouri J; Brunot A; Souissi T
    Tunis Med; 1995 Feb; 73(2):109-17. PubMed ID: 9506152
    [No Abstract]   [Full Text] [Related]  

  • 59. The incidence of H deficient A2 and A2B bloods and family studies on the AH-ABH status of an Aint and some new variant blood types (Aint H-A1, A2-HWA1, A2BHWA1B and A2-BHWA2B).
    Voak D; Lodge TW; Stapleton RR; Fogg H; Roberts HE
    Vox Sang; 1970 Jul; 19(1):73-84. PubMed ID: 5488661
    [No Abstract]   [Full Text] [Related]  

  • 60. [Accidental transfusion with ABO-incompatible blood: process for analysis of the contributing causes].
    Indrikovs AJ
    Sangre (Barc); 1997 Jun; 42(3):205-13. PubMed ID: 9381263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.